Ransom Advisory’s AbbVie ABBV Stock Holding History

Ransom Advisory’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$2.97M	Hold	12,995	–	–	1.17%	16
2025 Q3	$3.01M	Sell	12,995 -220	-2%	-$44.8K	1.36%	16
2025 Q2	$2.45M	Hold	13,215	–	–	1.16%	21
2025 Q1	$2.77M	Sell	13,215 -200	-1%	-$38.9K	1.37%	17
2024 Q4	$2.38M	Buy	13,415 +200	+2%	+$36.8K	1.1%	20
2024 Q3	$2.61M	Sell	13,215 -23	-0.2%	-$4.29K	1.22%	20
2024 Q2	$2.27M	Buy	13,238 +182	+1%	+$30.1K	1.14%	20
2024 Q1	$2.38M	Buy	+13,056	New	+$2.25M	1.27%	20

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Ransom Advisory's ABBV Position: Q4 2025 in Review

Ransom Advisory held its AbbVie (ABBV) position steady in Q4 2025 at 12,995 shares worth $2.97M. The position accounts for 1.17% of the portfolio, ranked #16.

Ransom Advisory first reported a position in ABBV in Q1 2024 and has held it in 8 quarters since. The position peaked at $3.01M in Q3 2025. 4,147 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.

Ransom Advisory held 12,995 shares of AbbVie worth $2.97M as of Q4 2025.
Ransom Advisory left its AbbVie share count unchanged in Q4 2025.
AbbVie made up 1.17% of Ransom Advisory's portfolio in Q4 2025, its #16 holding.
Ransom Advisory first reported a position in AbbVie in Q1 2024 and has held it in 8 quarters since.
Ransom Advisory's AbbVie position peaked at $3.01M in Q3 2025.
4,147 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.

Based on Ransom Advisory's 13F filing for Q4 2025, filed 6 Jan 2026.